Page 66 - Merck Sharp News Today

The Pan-African “Investing in Innovation” program will provide grants and commercialization support to 60 healthtech companies over two years. Healthcare consulting firm Salient Advisory has launched its latest market intelligence report highlighting promising African healthtech start-ups in supply chain. Spurred by these findings, a consortium of global and continental organizations, with funding from Bill and

Plaintiff Megan Marie Roeder filed suit on Wednesday in the Central District of California against defendants Merck & Co., Inc. and Merck Sharp &

In a retrospective study, Carlos King Ho Wong, Kristy Tsz Kwan Lau, and colleagues study adverse events reported following COVID-19 vaccination in Hong Kong.

/PRNewswire/ -- DelveInsights Metastatic Castration-Sensitive Prostate Cancer Market Insights report proffers a detailed comprehension of the Metastatic...

Metastatic Castration-Sensitive Prostate Cancer market dynamics is anticipated to witness a significant growth owing to the rising prevalence of prostate cancer cases due to the rapidly aging

Time-limited venetoclax, obinutuzumab and ibrutinib or venetoclax plus obinutuzumab prolonged PFS compared with chemoimmunotherapy among fit, previously untreated patients with chronic lymphocytic leukemia, according to study results.The preplanned interim analysis of the international, randomized phase 3 GAIA/CLL13 trial, presented during European Hematology Association Hybrid 2022 Congress,

/PRNewswire/ -- DelveInsights Systemic Lupus Erythematosus Market Insights report proffers a detailed comprehension of the Systemic Lupus Erythematosus market...

BERLIN--(BUSINESS WIRE)--Regulatory News:NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), announced today it has entered into a material transfer agreement with the U.S. National Cancer Institute (NCI), of...

Xilio Therapeutics (NASDAQ:XLO – Get Rating) and NGM Biopharmaceuticals (NASDAQ:NGM – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, institutional ownership, valuation, dividends, earnings and profitability. Insider and Institutional Ownership 72.3% of Xilio Therapeutics shares […]

Announced Publication of ADXS-PSA Data in The Oncologist Presented Updated Clinical and Immunogenicity Data from Ongoing Phase 1/2 Trial of ADXS-503 in...